title: A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".
authors: Rachel
authors: R
authors: Allen
authors: Andres
authors: A
authors: Brainsky
authors: Kelly
authors: K
authors: Grotzinger
authors: Tito
authors: T
authors: Roccia
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical / Q000379:methods*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles